Is Aquestive Therapeutics, Inc. (AQST) a Buy, Sell, or Hold?
Aquestive Therapeutics, Inc.
NASDAQ:AQST
$3.9645 USD
-$0.08 (-1.87%)
- Volume
- 1.43M
- Average Volume
- 1.79M
- Market Capitalization
- $393.7M
- P/E Ratio
- -6.50
- Dividend Yield
- 0.00%
- Price Target
- $9.00
- Year High
- $7.55
- Year Low
- $2.93
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.10
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
33
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
33
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 1.67M
AQST Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
AQST Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Krop Julie | director | 2026-06-23 | M-Exempt | 0.7132 | 2026-06-24 |
| Krop Julie | director | 2026-06-23 | S-Sale | 5.0157 | 2026-06-24 |
| Krop Julie | director | 2026-06-23 | M-Exempt | 0.7132 | 2026-06-24 |
| Barber Daniel | officer: President and CEO | 2026-06-15 | S-Sale | 4.1604 | 2026-06-16 |
| MORRIS TIMOTHY E | director | 2026-06-10 | A-Award | 3.99 | 2026-06-12 |
| Krop Julie | director | 2026-06-10 | A-Award | 3.99 | 2026-06-12 |
| Jenkins Abigail L. | director | 2026-06-10 | A-Award | 3.99 | 2026-06-12 |
| Cochran John | director | 2026-06-10 | A-Award | 3.99 | 2026-06-12 |
| BROWN GREGORY B | director | 2026-06-10 | A-Award | 3.99 | 2026-06-12 |
| Taglietti Marco | director | 2026-06-10 | A-Award | 3.99 | 2026-06-12 |
| Korczynski Sherry | officer: Chief Commercial Officer | 2026-06-08 | F-InKind | 0 | 2026-06-09 |
| Zalewski Thomas A. | officer: Chief Legal Officer | 2026-05-18 | A-Award | 0 | 2026-05-19 |
| Zalewski Thomas A. | officer: Chief Legal Officer | 2026-05-18 | A-Award | 4.135 | 2026-05-19 |
| Barber Daniel | officer: President and CEO | 2026-05-15 | S-Sale | 4.2889 | 2026-05-18 |
| Cioffi Melina | officer: SVP, Regulatory Affairs | 2026-05-15 | F-InKind | 4.17 | 2026-05-18 |
| BRAENDER LORI J | officer: Corporate Secretary | 2026-05-07 | F-InKind | 4.23 | 2026-05-11 |
| Boyd Peter E. | officer: Chief People Officer | 2026-05-05 | F-InKind | 4.18 | 2026-05-07 |
| Barber Daniel | officer: President and CEO | 2026-05-05 | F-InKind | 4.18 | 2026-05-07 |
| TOTH A ERNEST JR | officer: Chief Financial Officer | 2026-05-05 | F-InKind | 4.18 | 2026-05-07 |
| Jung Cassie | officer: Chief Operating Officer | 2026-05-05 | F-InKind | 4.18 | 2026-05-07 |
| BRAENDER LORI J | officer: Corporate Secretary | 2026-05-05 | F-InKind | 4.18 | 2026-05-07 |
| Barber Daniel | officer: President and CEO | 2025-03-07 | A-Award | 0 | 2026-04-13 |
| Boyd Peter E. | officer: Chief People Officer | 2025-03-07 | A-Award | 0 | 2026-04-13 |
| Jung Cassie | officer: Chief Operating Officer | 2025-03-07 | A-Award | 0 | 2026-04-13 |
| TOTH A ERNEST JR | officer: SVP, Chief Financial Officer | 2025-03-07 | A-Award | 0 | 2026-04-13 |
| Korczynski Sherry | officer: Chief Commercial Officer | 2025-03-07 | A-Award | 0 | 2026-04-13 |
| BRAENDER LORI J | officer: Corporate Secretary | 2025-03-07 | A-Award | 0 | 2026-04-13 |
| Zalewski Thomas A. | officer: Chief Legal Officer | 2026-04-02 | 0 | 2026-04-10 | |
| Boyd Peter E. | officer: Chief People Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Boyd Peter E. | officer: Chief People Officer | 2026-03-10 | S-Sale | 4.173 | 2026-03-11 |
| Boyd Peter E. | officer: Chief People Officer | 2026-03-09 | A-Award | 4.29 | 2026-03-11 |
| Barber Daniel | officer: President and CEO | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Barber Daniel | officer: President and CEO | 2026-03-10 | S-Sale | 4.173 | 2026-03-11 |
| Barber Daniel | officer: President and CEO | 2026-03-09 | A-Award | 4.29 | 2026-03-11 |
| BRAENDER LORI J | officer: Chief Legal Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| BRAENDER LORI J | officer: Chief Legal Officer | 2026-03-10 | S-Sale | 4.173 | 2026-03-11 |
| BRAENDER LORI J | officer: Chief Legal Officer | 2026-03-09 | A-Award | 4.29 | 2026-03-11 |
| Cioffi Melina | officer: SVP, Regulatory Affairs | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Cioffi Melina | officer: SVP, Regulatory Affairs | 2026-03-10 | S-Sale | 4.173 | 2026-03-11 |
| Cioffi Melina | officer: SVP, Regulatory Affairs | 2026-03-09 | A-Award | 4.29 | 2026-03-11 |
| TOTH A ERNEST JR | officer: Chief Financial Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| TOTH A ERNEST JR | officer: Chief Financial Officer | 2026-03-10 | S-Sale | 4.173 | 2026-03-11 |
| TOTH A ERNEST JR | officer: Chief Financial Officer | 2026-03-09 | A-Award | 4.29 | 2026-03-11 |
| Korczynski Sherry | officer: Chief Commercial Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Korczynski Sherry | officer: Chief Commercial Officer | 2026-03-10 | S-Sale | 4.173 | 2026-03-11 |
| Korczynski Sherry | officer: Chief Commercial Officer | 2026-03-09 | A-Award | 4.29 | 2026-03-11 |
| Jung Cassie | officer: Chief Operating Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Jung Cassie | officer: Chief Operating Officer | 2026-03-10 | S-Sale | 4.173 | 2026-03-11 |
| Jung Cassie | officer: Chief Operating Officer | 2026-03-09 | A-Award | 4.29 | 2026-03-11 |
| Davis Matthew W. | officer: Chief Development Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Davis Matthew W. | officer: Chief Development Officer | 2026-03-09 | A-Award | 4.29 | 2026-03-11 |
| Greenhawt Matthew J. | officer: Chief Medical Officer | 2026-03-09 | A-Award | 0 | 2026-03-11 |
| Greenhawt Matthew J. | officer: Chief Medical Officer | 2026-03-09 | A-Award | 4.29 | 2026-03-11 |
| Greenhawt Matthew J. | officer: Chief Medical Officer | 2026-03-02 | 0 | 2026-03-11 | |
| Boyd Peter E. | officer: Chief People Officer | 2025-12-04 | A-Award | 0 | 2025-12-05 |
| Cioffi Melina | officer: SVP, Regulatory Affairs | 2025-12-02 | F-InKind | 5.93 | 2025-12-04 |
| Davis Matthew W. | officer: Chief Development Officer | 2025-11-10 | A-Award | 0 | 2025-11-12 |
| Davis Matthew W. | officer: Chief Development Officer | 2025-11-10 | A-Award | 5.58 | 2025-11-12 |
| Davis Matthew W. | 2025-11-03 | 0 | 2025-11-12 | ||
| Jung Cassie | officer: Chief Operating Officer | 2025-10-15 | M-Exempt | 3.1027 | 2025-10-17 |
| Jung Cassie | officer: Chief Operating Officer | 2025-10-15 | S-Sale | 7.01 | 2025-10-17 |
| Jung Cassie | officer: Chief Operating Officer | 2025-10-15 | M-Exempt | 3.1027 | 2025-10-17 |
| Kraus Carl N | officer: Chief Medical Officer | 2025-10-15 | S-Sale | 7 | 2025-10-17 |
| Boyd Peter E. | officer: See Remarks | 2025-10-15 | S-Sale | 7 | 2025-10-17 |
| Barber Daniel | director, officer: President and CEO | 2025-09-26 | S-Sale | 6.0343 | 2025-09-29 |
| Boyd Peter E. | officer: See Remarks | 2025-09-26 | S-Sale | 6.3 | 2025-09-29 |
| Barber Daniel | director, officer: President and CEO | 2025-09-19 | S-Sale | 6 | 2025-09-22 |
| Jung Cassie | officer: Chief Operating Officer | 2025-09-04 | M-Exempt | 0.7063 | 2025-09-08 |
| Jung Cassie | officer: Chief Operating Officer | 2025-09-04 | M-Exempt | 3.15 | 2025-09-08 |
| Jung Cassie | officer: Chief Operating Officer | 2025-09-04 | S-Sale | 5 | 2025-09-08 |
| Jung Cassie | officer: Chief Operating Officer | 2025-09-04 | M-Exempt | 0.7063 | 2025-09-08 |
| Jung Cassie | officer: Chief Operating Officer | 2025-09-04 | M-Exempt | 3.15 | 2025-09-08 |
| Boyd Peter E. | officer: See Remarks | 2025-09-05 | S-Sale | 5.3 | 2025-09-08 |
| Korczynski Sherry | officer: Chief Commercial Officer | 2025-08-14 | A-Award | 0 | 2025-08-15 |
| Kraus Carl N | officer: Chief Medical Officer | 2025-08-09 | F-InKind | 3.9 | 2025-08-12 |
| BROWN GREGORY B | director | 2025-06-11 | A-Award | 3.41 | 2025-06-12 |
| Krop Julie | director | 2025-06-11 | A-Award | 3.41 | 2025-06-12 |
| MORRIS TIMOTHY E | director | 2025-06-11 | A-Award | 3.41 | 2025-06-12 |
| Jenkins Abigail L. | director | 2025-06-11 | A-Award | 3.41 | 2025-06-12 |
| Cochran John | director | 2025-06-11 | A-Award | 3.41 | 2025-06-12 |
| Taglietti Marco | director | 2025-06-11 | A-Award | 3.41 | 2025-06-12 |
| Korczynski Sherry | officer: SVP Sales and Marketing | 2025-06-09 | F-InKind | 3.54 | 2025-06-10 |
| Cioffi Melina | officer: SVP, Regulatory Affairs | 2025-05-15 | A-Award | 0 | 2025-05-15 |
| Cioffi Melina | officer: SVP Regulatory Affairs | 2025-04-25 | 0 | 2025-05-07 | |
| Cioffi Melina | officer: SVP Regulatory Affairs | 2022-06-10 | 4.07 | 2025-05-07 | |
| Cioffi Melina | officer: SVP Regulatory Affairs | 2021-11-24 | 6.62 | 2025-05-07 | |
| Cioffi Melina | officer: SVP Regulatory Affairs | 2023-08-05 | 0.88 | 2025-05-07 | |
| Cioffi Melina | officer: SVP Regulatory Affairs | 2021-08-31 | 7.86 | 2025-05-07 | |
| Wargacki Stephen | officer: Chief Science Officer | 2025-03-07 | A-Award | 0 | 2025-03-11 |
| Wargacki Stephen | officer: Chief Science Officer | 2025-03-07 | F-InKind | 2.65 | 2025-03-11 |
| Wargacki Stephen | officer: Chief Science Officer | 2025-03-09 | F-InKind | 2.65 | 2025-03-11 |
| Wargacki Stephen | officer: Chief Science Officer | 2025-03-10 | F-InKind | 2.54 | 2025-03-11 |
| Wargacki Stephen | officer: Chief Science Officer | 2025-03-07 | A-Award | 2.65 | 2025-03-11 |
| Jung Cassie | officer: Chief Operating Officer | 2025-03-07 | A-Award | 0 | 2025-03-11 |
| Jung Cassie | officer: Chief Operating Officer | 2025-03-07 | F-InKind | 2.65 | 2025-03-11 |
| Jung Cassie | officer: Chief Operating Officer | 2025-03-09 | F-InKind | 2.65 | 2025-03-11 |
| Jung Cassie | officer: Chief Operating Officer | 2025-03-10 | F-InKind | 2.54 | 2025-03-11 |
| Jung Cassie | officer: Chief Operating Officer | 2025-03-07 | A-Award | 2.65 | 2025-03-11 |
| TOTH A ERNEST JR | officer: Chief Financial Officer | 2025-03-07 | A-Award | 0 | 2025-03-11 |
| TOTH A ERNEST JR | officer: Chief Financial Officer | 2025-03-07 | F-InKind | 2.65 | 2025-03-11 |